October 7, 2009

OrthAlign receives KneeAlign^® 510(k) Market Clearance from US Food and Drug Administration

Irvine, CA - October 7, 2009 - OrthAlign, Inc., Irvine, CA - October 7, 2009 - OrthAlign, Inc., a privately held medical device company in Orange County, CA, received a 510(k) market clearance letter from the US Food and Drug Administration, confirming that its KneeAlign^® disposable computer-assisted surgical ("CAS") navigation system for total knee arthroplasty procedures is substantially equivalent to currently marketed CAS systems.

"Our team is pleased to have achieved this important milestone. Since inception in 2008, we have taken significant steps forward with the development of our computer-assisted technology for orthopedic surgery, resulting in this market clearance", said Pieter Wolters, OrthAlign's President and CEO. "We believe that KneeAlign^® will be cost effective and become the new standard of care in orthopedic surgery".

About OrthAlign, Inc.:

OrthAlign has developed disposable palm-sized, computer-assisted surgical devices for use in total jointreplacement. The company received regulatory clearance for clinical use of its first generation KneeAlign^® product in the United States in September 2009.

For more information, visit www.orthalign.com.